Biotech sell-off continues as investors turn to safer assets amid rising inflation - Investment Week

Retrieved on: 2022-02-10 08:23:30

Tags for this article:

Click the tags to see associated articles and topics

Biotech sell-off continues as investors turn to safer assets amid rising inflation - Investment Week. View article details on hiswai:

Excerpt

... the last two years, 83% of recent biotech listings are now trading at a stock price well below their IPO price, according to Refinitiv data.

Article found on: www.investmentweek.co.uk